Abstract
BackgroundOncolytic viral immunotherapy utilizes viruses that preferentially infect and replicate within cancer cells, resulting in both tumor cell destruction and activation of an anti-tumor immune response. However, a major obstacle...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
